Evaluation of the updated 2022 lung-GPA in NSCLC adenocarcinoma patients with brain metastases: analysis of prognostic factors in a German clinical cohort.

Radiat Oncol · 2026 · PMC12964932 · PMID 41736058

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp-value < 0.0001actually significant

As demonstrated in our German cohort, the prognostic performance of the NSCLC-GPA remained highly significant, with a p-value < 0.0001 based on Kaplan-Meier analysis (Fig. 1 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.